The world-famous paper by FDA/NIH researchers reporting that they found evidence of XMRV in ME/CFS patients’ blood will be published “within weeks,” according to the CFIDS Association of America.
A posting dated Friday July 9 on the CFIDS Association Facebook page notes that a sentence has been added to their article titled “XMRV Link Accelerates Scientific and Media Interest.”
Specifically, the revised article now states, at the end of the eighth paragraph: “The researchers have conducted additional experiments as requested by the reviewers and their paper is expected to be published in the Proceedings of the National Academy of Sciences within weeks.”
Though no source is cited, the CAA further commented (just before 11 am Pacific time, July 9) on Facebook that “The information comes from several well-informed people close to the study with whom we are in regular contact.”
July 12 Post Scripts:
Mindy Kitei reported on CFSCentral.com that PNAS editor-in-chief Dr. Randy Schekman informed her they expect the positive paper’s authors to return it to them for standard editorial board consideration “within weeks.”
There still seems to be time to register for the CAA’s July 15 XMRV webinar. Columbia University virologist Vincent Racaniello and expert ME/CFS/FM physician Lucinda Bateman, MD, will discuss the future of XMRV-CFS research and what we’re likely to learn.
And see Cort Johnson’s excellent July 12 report on his recent interview with Dr. Racaniello & the WPI’s Dr. Judy Mikovits (“A different kind of XMRV?”), in which they speculate on technical reasons why the CDC researchers and others have not been able to detect XMRV in CFS patients’ blood.